Biophan to Acquire Maker of MRI Compatibles

Biophan Technologies, Inc. (Rochester, NY, USA), a developer of next-generation biomedical technology, has agreed to acquire Amris GmbH (Castrop-Rauxel, Germany), a German-based manufacturer of magnetic resonance imaging (MRI)-safe and image-compatible technology systems and biomedical devices.

Under the agreement, Biophan will also acquire the exclusive rights to 15 issued and pending patents covering imaging of devices including stents and other vascular implants. The acquisition of Amris will provide Biophan with a range of products, technologies, and scientific expertise that extends the company's intellectual property portfolio of medical systems in the fast-growing field of MRI-compatible products and procedures.

"The Amris technology complements Biophan's very effectively and expands our scientific capabilities significantly,” stated Biophan's CEO, Michael Weiner.

Following the acquisition, Amris will be renamed Biophan Europe. Among the Amris technology products are an MRI-visible catheter marker, MRI-visible stent, and a series of MRI-visible medical devices in development. Certain implantable devices, including stents, cannot be imaged for restenosis re-occurrence with MRI, because of signal interference caused by the stent, which creates a Faraday Cage effect. As a result, patients with these devices have to undergo invasive procedures using nephrotoxic allergenic contrast media under radiation-emitting x-rays. With this new technology, restenosis re-occurrence can be safely visualized with MRI.



Related Links:
Biophan Technologies
Amris